EyePoint Pharmaceuticals Inc (EYPT)
11.32
-0.27
(-2.33%)
USD |
NASDAQ |
Nov 08, 10:00
EyePoint Pharmaceuticals Revenue (Annual): 46.02M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 46.02M |
| December 31, 2022 | 41.40M |
| December 31, 2021 | 36.94M |
| December 31, 2020 | 34.44M |
| December 31, 2019 | 20.36M |
| December 31, 2018 | 2.928M |
| June 30, 2018 | 2.961M |
| June 30, 2017 | 7.539M |
| June 30, 2016 | 1.62M |
| June 30, 2015 | 26.56M |
| June 30, 2014 | 3.473M |
| June 30, 2013 | 2.143M |
| Date | Value |
|---|---|
| June 30, 2012 | 3.526M |
| June 30, 2011 | 4.965M |
| June 30, 2010 | 23.05M |
| June 30, 2009 | 12.16M |
| June 30, 2008 | 3.476M |
| June 30, 2007 | 2.235M |
| June 30, 2006 | 1.465M |
| June 30, 2005 | 0.6243M |
| June 30, 2004 | 0.2652M |
| June 30, 2003 | 0.0744M |
| June 30, 2002 | 0.5163M |
| June 30, 2001 | 0.0577M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
20.36M
Minimum
2019
46.02M
Maximum
2023
35.83M
Average
36.94M
Median
2021
Revenue (Annual) Benchmarks
| Cassava Sciences Inc | -- |
| Adverum Biotechnologies Inc | 3.60M |
| Regenxbio Inc | 90.24M |
| Editas Medicine Inc | 78.12M |
| Apellis Pharmaceuticals Inc | 396.59M |